Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Bionomics plans IND for vascular disruption agent BNC-105

Jan. 19, 2007

GP-Pharm receives U.S. orphan drug status for Sarcodoxome

Jan. 19, 2007

AZD-2171 normalizes tumor vasculature in patients with glioblastoma

Jan. 18, 2007

Tumor necrosis therapy product launched in China for lung cancer

Jan. 18, 2007

Sunitinib found superior to interferon alfa in metastatic renal cell cancer

Jan. 18, 2007

Glufosfamide begins phase I study in Japan

Jan. 18, 2007

FDA awards orphan drug status to Marqibo for ALL

Jan. 18, 2007

Fodosine begins pivotal study for relapsed or refractory T-cell leukemia/lymphoma

Jan. 18, 2007

Novel DPP II inhibitor characterized at ActivX

Jan. 18, 2007

Novel treatments for cancer covered in recent patent literature

Jan. 18, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 15, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...